SF-36 mean T-scores of rhGH-treated patients, stratified by indication groups and compared to Swiss controls.

<p>Fig 2 shows mean T-scores for the eight SF-36 subscales and the two summary scores of rhGH treated patients, stratified by indication groups and compared to Swiss controls. Swiss controls means were unadjusted. Higher T-scores indicate higher HRQoL (expected mean from German norm population = 50, SD = 10). P-values to compare means between rhGH treated patients and Swiss controls were calculated using linear regression models.^aGroup I includes healthy patients with IGHD or ISS; ^bGroup II patients with associated diseases or syndromes; ^cGroup III childhood cancer survivors with GHD. Abbreviations: GHD, growth hormone deficiency; IGHD, isolated growth hormone deficiency; ISS, idiopathic short stature; rhGH, recombinant human growth hormone; SF-36, Short Form-36.